钥匙(锁)
药物发现
药物开发
政府(语言学)
业务
风险分析(工程)
药品
发展中国家
医学
经济增长
药理学
计算机科学
经济
生物信息学
计算机安全
生物
语言学
哲学
作者
Michael Dickson,Jean Paul Gagnon
摘要
The public desire for new therapies, their increasing cost and the increased role of government as a payer for innovative new drugs all converge on the issue of the rapidly rising cost of new drug development — now thought to be greater than US $800 million — and highlight the necessity for an efficient use of resources. With this in mind, here we review studies on the cost of developing new drugs and consider how this cost has, and could be, affected by the changing environment for pharmaceutical research and development.
科研通智能强力驱动
Strongly Powered by AbleSci AI